gefitinib has been researched along with betadex in 5 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (betadex) | Trials (betadex) | Recent Studies (post-2010) (betadex) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 8,785 | 97 | 4,452 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boerner, JL; Bohin, N; Ge, Y; Irwin, ME; Mueller, KL | 1 |
Hu, X; Huang, Y; Lee, RJ; Li, H; Xiang, G; Yung, B; Zhou, X | 1 |
Cui, W; Feng, B; Li, H; Liu, L; Liu, M; Shi, Y; Su, C; Su, R; Zhao, L | 1 |
Abbas, A; Basak, S; Bhattacharya, P; Deep Punetha, V; Dey, S; Gopal Sahoo, N; Mondal, S; Saha, A | 1 |
Deep Kaur, C; Gidwani, B; Vyas, A | 1 |
5 other study(ies) available for gefitinib and betadex
Article | Year |
---|---|
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
Topics: Atorvastatin; Benzylamines; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; ErbB Receptors; Female; Gefitinib; Heptanoic Acids; Humans; Lovastatin; Membrane Microdomains; Phosphorylation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Thiophenes | 2011 |
Novel liposomal gefitinib (L-GEF) formulations.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Cell Line, Tumor; Drug Stability; Gefitinib; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Inbred ICR; Particle Size; Quinazolines | 2012 |
Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Autophagy; beta-Cyclodextrins; Cell Survival; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; Gefitinib; HeLa Cells; Humans; Molecular Targeted Therapy; Nanoparticles; Quinazolines; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared | 2014 |
Fabrication of β-cyclodextrin-mediated single bimolecular inclusion complex: characterization, molecular docking, in-vitro release and bioavailability studies for gefitinib and simvastatin conjugate.
Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; beta-Cyclodextrins; Biological Availability; Drug Carriers; Drug Compounding; Drug Liberation; Female; Gefitinib; Male; Mice; Molecular Docking Simulation; Quinazolines; Rats, Wistar; Simvastatin; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |
Investigation of inclusion behaviour of gefitinib with epichlorohydrin-β-cyclodextrin polymer: preparation of binary complex, stoichiometric determination and characterization.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Calorimetry, Differential Scanning; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Epichlorohydrin; Freeze Drying; Gefitinib; Polymers; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2018 |